Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marlena Szalata is active.

Publication


Featured researches published by Marlena Szalata.


Experimental and Molecular Pathology | 2010

Association of c.802C>T polymorphism of NOD2/CARD15 gene with the chronic gastritis and predisposition to cancer in H. pylori infected patients

Andrzej Hnatyszyn; Marlena Szalata; Jerzy Stanczyk; Wojciech Cichy; Ryszard Słomski

This paper shows analysis of the association of the 802C>T polymorphism of the NOD2/CARD15 gene with the occurrence of the chronic inflammation of the gastric mucosa associated with the Helicobacter pylori infections, development of intestinal metaplasia and dysplasia and, in the result of this, gastric cancer. Genomic DNA samples were extracted from paraffin blocks of gastric mucosal biopsies and from peripheral blood. H. pylori infection was confirmed by histological analysis and urease test. Pyrosequencing of 802C>T polymorphism of the NOD2/CARD15 gene was performed for H. pylori infected patients (131) and population group (100). Analysis of the NOD2/CARD15 gene showed that frequency of the T allele was significantly higher (32.8%) in the group of patients in comparison with the population group (18.1%), with the relative risk of 1.8. In the patient group, the frequency of the CC genotype was 51.1%, CT 32.1% and TT 16.8% (relative risk: 0.7, 1.1 and 4.2, respectively), while in the population group it was 69.0%, 25.7% and 5.3% (relative risk: 1.0, 0.9 and 1.3, respectively). The increasing frequency of the T allele and CT and TT genotypes in the patients with increasingly deeper changes in the gastric mucosa becomes apparent. Our findings suggest that polymorphism 802C>T is associated with changes in gastric mucosa and plays a significant role in the initiation and the progression of carcinogenesis. The number of observed mutations in gastric mucosa correlated with severity of disease.


Advances in Medical Sciences | 2013

The impact of genetic factors on response to anaesthetics

Adam Mikstacki; Marzena Skrzypczak-Zielinska; Barbara Tamowicz; Oliwia Zakerska-Banaszak; Marlena Szalata; Ryszard Słomski

In recent years, exceptional progress has been observed in pharmacogenetics, i.e. investigations of inherited conditioning of the organisms response to drugs or xenobiotics. On the other hand, modern molecular biology techniques have been implemented, making it possible to perform studies determining the involvement of genetic factors in differing responses to agents employed in general anaesthesia. Unexpected and incorrect response of the organism to the administration of specific anaesthetics is most commonly associated with a genetic defect of the metabolic pathway of a given agent or its receptor. The majority of agents used in anaesthesia are metabolised in the liver by the cytochrome P450 superfamily enzymes (CYPs) and phase II drug-metabolising enzymes: glutathione S-transferases (GSTs), sulphotransferases (SULTs), UDP-glucuronosyltransferases (UGTs) and NAD(P)H:quinone oxidoreductase (NQO1). Propofol is presently widely used for gastrointestinal (GI) and several other procedures. Among genes associated with metabolism of the most commonly applied anaesthetics such as propofol and sevoflurane, the following ones can be mentioned: CYP2E1, CYP2B6, CYP2C9, GSTP1, UGT1A9, SULT1A1 and NQO1. Moreover, the basic mechanism of propofol action involves its interaction with an ionotropic receptor GABAA inhibiting transfer of nerve impulses. Molecular studies have shown that polymorphic changes in GABRG2 receptor gene turn out to be important in the propofol anaesthesia. Planning of optimal anaesthesia can be considerably assisted by the determination of genetic factors of prognostic value taking advantage of genotyping and making it possible to select anaesthetics and reduce risk of side effects as well as undesirable actions.


Biology of Reproduction | 2006

Generation of Transgenic Rabbits by the Novel Technique of Chimeric Somatic Cell Cloning

M. Skrzyszowska; Z. Smorąg; Ryszard Słomski; L. Kątska-Książkiewicz; R. Kalak; E. Michalak; K. Wielgus; J. Lehmann; Daniel Lipiński; Marlena Szalata; A. Pławski; M. Samiec; J. Jura; B. Gajda; B. Ryńska; M. Pieńkowski

Abstract A novel technique of chimeric somatic cell cloning was applied to produce a transgenic rabbit (NT20). Karyoplasts of transgenic adult skin fibroblasts with Tg(Wap-GH1) gene construct as a marker were microsurgically transferred into one, previously enucleated, blastomere of 2-cell non-transgenic embryos, while the second one remained intact. The reconstructed embryos either were cultured in vitro up to the blastocyst stage (Experiment I) or were transferred into recipient-females immediately after the cloning procedure (Experiment II). In Experiment I, 25/102 (24.5%) embryos formed blastocysts from whole embryos and 46/102 (44.12%) embryos developed to the blastocyst stage from single non-operated blastomeres, while the reconstructed blastomeres were damaged and degenerated. Thirteen (12.7%) embryos did not exceed 3- to 4-cell stages and 18 (17.7%) embryos were inhibited at the initial 2-cell stage. Out of 14 blastocysts which were subjected to molecular analysis, the transgene was detected in the cells of 4 blastocysts. In Experiment II, 163/217 (75.0%) embryos were transferred into 9 pseudopregnant recipient-rabbits (an average of 18 embryos per recipient). Four recipient-females (44.4%) became pregnant and delivered a total of 24 (14.7%) pups. Molecular analysis confirmed that two pups (1.2%), one live and one stillborn, showed a positive transgene signal. Live transgenic rabbit NT20 appeared healthy and anatomically as well as physiologically normal. The results of our experiments showed that transgenic adult skin fibroblast cell nuclei, which have been introduced into the cytoplasmic microenvironment of single enucleated blastomeres from 2-cell stage rabbit embryos, are able to direct the development of chimeric embryos not only to the blastocyst stage but also up to term.


Journal of Applied Genetics | 2013

Transgenic pigs designed to express human α-galactosidase to avoid humoral xenograft rejection.

Joanna Zeyland; Gawrońska B; Wojciech Juzwa; Jacek Jura; Agnieszka Nowak; Ryszard Słomski; Zdzisław Smorąg; Marlena Szalata; Anna Woźniak; Daniel Lipiński

The use of animals as a source of organs and tissues for xenotransplantation can overcome the growing shortage of human organ donors. However, the presence of xenoreactive antibodies in humans directed against swine Gal antigen present on the surface of xenograft donor cells leads to the complement activation and immediate xenograft rejection as a consequence of hyperacute reaction. To prevent hyperacute rejection, it is possible to change the swine genome by a human gene modifying the set of donor’s cell surface proteins. The gene construct pGal-GFPBsd containing the human gene encoding α-galactosidase enzyme under the promoter of EF-1α elongation factor ensuring systemic expression was introduced by microinjection into a male pronucleus of the fertilised porcine oocyte. As a result, the founder male pig was obtained with the transgene mapping to chromosome 11p12. The polymerase chain reaction (PCR) analysis revealed and the Southern analysis confirmed transgene integration estimating the approximate number of transgene copies as 16. Flow cytometry analysis revealed a reduction in the level of epitope Gal on the cell surface of cells isolated from F0 and F1 transgenic animals. The complement-mediated cytotoxicity assay showed increased viability of the transgenic cells in comparison with the wild-type, which confirmed the protective influence of α-galactosidase expression.


Acta Theriologica | 2008

Is G→T substitution in the sequence of CAG repeats within the androgen receptor gene associated with aggressive behaviour in the red foxVulpes vulpes?

Piotr Gronek; Piotr Przysiecki; Sławomir Nowicki; Robert Kalak; Wojciech Juzwa; Marlena Szalata; Ryszard Słomski; Joanna Lehmann; Dariusz Brzeziński; Wojciech Lassociński

Studies were carried out on one of the largest European red foxVulpes vulpes (Linnaeus, 1758) farms in Śniaty and Batorówka (Poland). A test created by Nowicki and Przysiecki (NP) was used to describe behaviour of the animals. The results of the NP behaviour test showed 4 types of behaviour in foxes: aggressive, curious, indifferent and apprehensive. While analyzing a fragment of exon 1 in the androgen receptor gene in 184 individuals, four alleles were found, ie 10, 10T, 12 and 13. The most frequent allele was allele 10, both in males and females (65.85 and 57.39%, respectively). The next in order of frequency were allele 10T (24.39 and 31.25%), 13 (7.32 and 9.09%) and 12 (2.44 and 2.27%, respectively). On the basis of further analysis an association was shown between behaviour of the red fox and its genotype. In aggressive females allele 10 was found significantly more frequently (76%) than in curious females (57%). While analyzing the genotypes of aggressive females it was shown that there were 15 individuals with genotype 10/10 (15.56%), 11 heterozygotes (9.87%) and only 1 individual with genotype 10T/10T (1.56%). In curious females the distribution of these genotypes was 15 (13.71%), 18 (20.57%) and 9 (7.71%), respectively. Although the result of Pearson Χ2 analysis was not significant (Χ2,p=0.0793), the Armitage’s chi-squared test for trend showed a significant difference Χ2,p=0.0305). This results may suggest that the androgen receptor gene may be suitable in studies on psychological traits.


European Journal of Drug Metabolism and Pharmacokinetics | 2013

Genotype and allele frequencies of polymorphic UGT1A9 in the Polish population

Oliwia Zakerska; Marzena Skrzypczak-Zielinska; Adam Mikstacki; Barbara Tamowicz; Bianka Malengowska; Marlena Szalata; Ryszard Słomski

The human UDP-glucuronosyltransferase 1A9 (UGT1A9) plays a central role in the metabolism of different therapeutic drugs, carcinogens and endobiotics. The UGT1A9 gene shows genetic polymorphism with frequencies significantly different in populations and ethnic groups. Many of these genetic variants are directly responsible for polymorphic drug metabolism. Three crucial alleles of UGT1A9, UGT1A9*3 (p.Met33Thr), *4 (p.Tyr242X), *5 (p.Asp256Asn) are associated with decrease or absence of enzyme activity, which intensify the risk of toxic effect during biotransformation. The goal of the present study was to discover frequencies of these genetic variations in 308 healthy individuals representing Polish population. The genotypes were determined by pyrosequencing. We demonstrated that the frequency of the variant UGT1A9*3 was 0.016, which suggests the need for detailed analysis of its effect on important drugs metabolism level in Polish population. Alleles UGT1A9*4 and UGT1A9*5 were not present in any of the subjects. So far, no studies have been conducted in which the distribution of these alleles has been determined in the Polish population.


Polish Journal of Food and Nutrition Sciences | 2016

Identification of bovine, pig and duck meat species in mixtures and in meat products on the basis of the mtDNA cytochrome oxidase subunit I (COI) gene sequence.

Anita Spychaj; Marlena Szalata; Ryszard Słomski; Edward Pospiech

Abstract The aim of this study was to develop a method using PCR and self-designed primers on the basis of the mtDNA cytochrome oxidase subunit I (COI) gene sequence to enable direct identification of the meat of three species of animals, i.e. bovines, pigs and ducks, in the single type sample, in meat mixtures and meat products. The mixtures comprised up to six meat species including apart from beef, pork and duck also chicken, turkey and goose meat. The obtained results indicate the possibility of qualitative identification of the aforementioned meat species in all types of investigated food products. The maximum length of PCR products did not exceed 300 bp, which was supposed to favour the amplification of DNA from meat products which are usually thermally processed and/or exposed to high pressure. PCR primers hybridised selectively with bovine, pig and duck DNA, showing total species specificity.


Transgenic Research | 2015

Screening pigs for xenotransplantation: expression of porcine endogenous retroviruses in transgenic pig skin.

Magdalena Kimsa-Dudek; Barbara Strzalka-Mrozik; Malgorzata W. Kimsa; Irena Blecharz; Joanna Gola; Bartłomiej Skowronek; Adrian Janiszewski; Daniel Lipiński; Joanna Zeyland; Marlena Szalata; Ryszard Słomski; Urszula Mazurek

Pigs seem to be the answer to worldwide organ donor shortage. Porcine skin may also be applied as a dressing for severe burns. Genetic modifications of donor animals enable reduction of immune response, which prolongs xenograft survival as temporary biological dressing and allows achieving resistance against xenograft rejection. The risk posed by porcine endogenous retroviruses (PERVs) cannot be eliminated by breeding animals under specific-pathogen-free conditions and so all recipients of porcine graft will be exposed to PERVs. Therefore our study has been focused on the assessment of PERV DNA and mRNA level in skin samples of transgenic pigs generated for xenotransplantation. Porcine skin fragments were obtained from 3- to 6-month-old non-transgenic and transgenic Polish Landrace pigs. Transgenic pigs were produced by pronuclear DNA microinjection and were developed to express the human α-galactosidase and the human α-1,2-fucosyltransferase gene. The copy numbers of PERV DNA and RNA were evaluated using real-time Q-PCR and QRT-PCR. Comparative analysis of all PERV subtypes revealed that PERV-A is the main subtype of PERVs in analyzed skin samples. There was no significantly different copy number of PERV-A, PERV-B and PERV-C between non-transgenic pigs, pigs with the human α-galactosidase and pigs expressing the human α-1,2-fucosyltransferase gene, except of PERV-C DNA. It brings the conclusion, that transgenesis process exerts no influence on PERVs transinfection. That is another step forward in the development of pig skin xenografts as burn wounds dressing.


Journal of Clinical Anesthesia | 2015

Glutathione S-transferase as a toxicity indicator in general anesthesia: genetics and biochemical function

Adam Mikstacki; Oliwia Zakerska-Banaszak; Marzena Skrzypczak-Zielinska; Barbara Tamowicz; Marlena Szalata; Ryszard Słomski

General anesthesia may lead in patients to unexpected and adverse reactions including toxicity. Glutathione S-transferases (GSTs) are enzymes responsible for the detoxification process of anesthetic agents. Plasma and urine GST measurements are used in multiple studies as a hepatocellular integrity or renal injury indicator. The importance of GST enzyme measurements in monitoring the hepatotoxic and nephrotoxic effect in anesthetized patients is presented. The biochemical function and specific properties of GST render it a prognostic biomarker. This review demonstrates that GST can be valuable and promising toxicity indicator in patients undergoing general anesthesia.


Genetic Testing and Molecular Biomarkers | 2013

High-resolution melting analysis of the TPMT gene: a study in the Polish population.

Marzena Skrzypczak-Zielinska; Pawel Borun; Katarzyna Milanowska; Ludwika Jakubowska-Burek; Oliwia Zakerska; Agnieszka Dobrowolska-Zachwieja; Andrzej Plawski; Ursula G. Froster; Marlena Szalata; Ryszard Słomski

The thiopurine S-methyltransferase (TPMT) gene encoding thiopurine methyltransferase is a crucial enzyme in metabolism of thiopurine drugs: azathioprine and 6-mercoptopurine, which are used in the treatment of leukemia or inflammatory bowel diseases. Genetic polymorphism of the TPMT gene correlates with activity of this enzyme, individual reaction, and dosing of thiopurines. Thirty-one variants of the TPMT gene with low enzymatic activity have been described with three major alleles: TPMT*2 (c.238G>C), *3A (c.460 G>A, c.719A>G), and *3C (c.719A>G), accounting for 80% to 95% of inherited TPMT deficiency in different populations in the world. The aim of the study was to establish a rapid and highly sensitive method of analysis for the complete coding sequence of the TPMT gene and to determine the spectrum and prevalence of the TPMT gene sequence variations in the Polish population. Recently, high-resolution melting analysis (HRMA) has become a highly sensitive, automated, and economical technique for mutation screening or genotyping. We applied HRMA for the first time to TPMT gene scanning. In total, we analyzed 548 alleles of the Polish population. We found 11 different sequence variations, where two are novel changes: c.200T>C (p.P67S, TPMT*30) and c.595G>A (p.V199I, TPMT*31). Detection of these new rare alleles TPMT*30 and *31 in the Polish population suggests the need to analyze the whole TPMT gene and maybe also the extension of routinely used tests containing three major alleles, TPMT*2, *3A, and *3C. Identification of sequence variants using HRMA is highly sensitive and less time consuming compared to standard sequencing. We conclude that HRMA can be easy integrated into genetic testing of the TPMT gene in patients treated with thiopurines.

Collaboration


Dive into the Marlena Szalata's collaboration.

Top Co-Authors

Avatar

Ryszard Słomski

Polish Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Daniel Lipiński

Polish Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Adam Mikstacki

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Barbara Tamowicz

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar

Joanna Kempiak

Poznan University of Medical Sciences

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrzej Plawski

Polish Academy of Sciences

View shared research outputs
Top Co-Authors

Avatar

Grzegorz H. Bręborowicz

Poznan University of Medical Sciences

View shared research outputs
Researchain Logo
Decentralizing Knowledge